SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE
SIREN : 517571832
Mitarbeiter: 02 (2023.0)Rechtsform: SCA (commandite par actions)Größe: PMEGründungsdatum: 2009-09-03 (16 Jahre)Status: AktivBranche: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesStandort: COLMAR (68000), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE : revenue, balance sheet and financial ratios
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is a French company
founded 16 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in COLMAR (68000),
this company of category PME
shows in 2015 a revenue of 207 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Historique financier - SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE (SIREN 517571832)
Kennzahl
2017
2016
2015
Umsatz
N/C
N/C
207 070 €
Nettoergebnis
263 622 €
810 629 €
-891 637 €
EBITDA
N/C
N/C
1 982 €
Nettomarge
N/C
N/C
-430.6%
Umsatz und Gewinn- und Verlustrechnung
In 2017, SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE generates positive net income of 264 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Nettoergebnis (2017)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Verschuldungsgrad (2017)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
53.304%
Finanzielle Autonomie (2017)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2015
2016
2017
Verschuldungsgrad
-285.894
74.132
53.304
Finanzielle Autonomie
-17.442
36.765
52.383
Rückzahlungsfähigkeit
-1.294
None
None
Cashflow / Umsatz
-176.747%
None%
None%
Positionnement sectoriel
Debt ratio
53.32017
2015
2016
2017
Q1: 0.0
Méd: 6.83
Q3: 49.59
Average+50 pts über 3 Jahre
In 2017, the debt ratio of SOCIETE DE DEVELOPPEMENT ... (53.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.38%2017
2015
2016
2017
Q1: 14.21%
Méd: 37.04%
Q3: 60.18%
Good+42 pts über 3 Jahre
In 2017, the financial autonomy of SOCIETE DE DEVELOPPEMENT ... (52.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
-1.29 years2015
2015
Q1: -0.01 years
Méd: 0.0 years
Q3: 0.28 years
Excellent
In 2015, the repayment capacity of SOCIETE DE DEVELOPPEMENT ... (-1.29) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 2125.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2017)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
2125.225
Entwicklung der Liquiditätskennzahlen SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2015
2016
2017
Liquiditätsquote
163.851
1576.771
2125.225
Zinsdeckung
452.977
None
None
Positionnement sectoriel
Liquidity ratio
2125.222017
2015
2016
2017
Q1: 131.18
Méd: 189.43
Q3: 305.54
Excellent+32 pts über 3 Jahre
In 2017, the liquidity ratio of SOCIETE DE DEVELOPPEMENT ... (2125.22) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
452.98x2015
2015
Q1: 0.0x
Méd: 0.0x
Q3: 2.63x
Excellent
In 2015, the interest coverage of SOCIETE DE DEVELOPPEMENT ... (453.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Umlaufvermögensbedarf und Zahlungsfristen
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operatives Working Capital (2017)
?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität
0 j
Lagerumschlag (2017)
?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag
0 j
Entwicklung des Working Capital und der Zahlungsfristen SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2015
2016
2017
BFR d'exploitation
14 499 €
0 €
0 €
Lagerumschlag (Tage)
0
0
0
Crédit clients (jours)
234
0
0
Crédit fournisseurs (jours)
81
0
0
Positionnement de SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE dans son secteur
Vergleich mit der Branche Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Bewertungsschätzung
Based on 124 transactions of similar company sales
(all years),
the value of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is estimated at
216 569 €
(range 82 427€ - 790 884€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2017
124 transactions
82k€216k€790k€
216 569 €Range: 82 427€ - 790 884€
NAF 5 all-time
Valuation method used
Net Income Multiple
263 622 €
×
0.8x
=216 570 €
Range: 82 428€ - 790 885€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE with other companies in the same sector:
Frequently asked questions about SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE
What is the revenue of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?
The revenue of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE in 2015 is 207 k€.
Is SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE profitable?
Yes, SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE generated a net profit of 264 k€ in 2017.
Where is the headquarters of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?
The headquarters of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is located in COLMAR (68000), in the department Haut-Rhin.
Where to find the tax return of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?
The tax return of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE operate?
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen